Preclinical characterization of the efficacy and safety of histamine H3 receptor antagonist, LINS01022, as a novel analgesic for chronic neuropathic pain treatment
{{output}}
Neuropathic pain is a disorder that represents a significant clinical challenge, while is refractory to therapeutic interventions. Given that the histamine H3 receptor (H3R) is a promising target for new analgesics, we aimed to determine the effects of a novel... ...
